TEAM.NASDAQAtlassian CORP

Form 4: Atlassian Co-CEO Michael Cannon-Brookes Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4


Michael Cannon-Brookes, Co-CEO and Co-Founder of Atlassian, sold Class A Common Stock on February 27, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • Michael Cannon-Brookes, Co-CEO and Co-Founder of Atlassian, reported the sale of Class A Common Stock on February 27, 2024.
  • The sales were executed under a Rule 10b5-1 trading plan adopted on February 21, 2023.
  • A total of 8,241 shares were sold in multiple transactions at varying prices.
  • The weighted average sale prices ranged from $205.3656 to $207.9825.
  • The shares were indirectly held by CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust.
  • Following the reported transactions, Cannon-Brookes beneficially owns 181,302 to 188,153 shares indirectly through the trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock sales under a pre-arranged plan, which doesn't inherently indicate positive or negative sentiment about the company's prospects.

Positives

  • The sales were executed under a pre-arranged 10b5-1 trading plan, which is a legal and transparent way for insiders to sell shares.

Risks

  • Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by investors.

Future Outlook

The document does not contain any forward-looking statements regarding the company's future performance.

Industry Context

Insider trading activity is closely monitored in the tech industry, and Form 4 filings provide transparency into these transactions. Sales under 10b5-1 plans are common and generally viewed as less impactful than discretionary sales.

Stakeholder Impact

  • The stock sale could have a minor impact on shareholders if it creates downward pressure on the stock price, although sales under 10b5-1 plans are usually anticipated.

Key Dates

DateDescription
02/21/2023Date of adoption of Rule 10b5-1 trading plan
02/27/2024Date of stock sale transactions
02/28/2024Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.